Complete directory of ASX Listed Companies. Download (CSV) with Sectors & Market Caps. Includes ETFs & LICs. Links to company share prices and analysis.
We have introduced a series of value-added products which will offer sustained upsides in 10 22% Revenue Growth witnessed in Pharmaceuticals segment The growth momentum of the Company revenue and EBITDA is expected to continue to do well, with robust outlook performance from here on. Also the ...